Skip to content
Drug recall · FDA · Published March 15, 2019

Pfizer Inc. recalls Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia &

Pfizer recalls Cleocin phosphate injection due to impurities that could cause serious harm. Patients with prescription orders should check their medication details and contact Pfizer for guidance.

🇺🇸 FDA recall #D-1069-2019DrugPfizer ›
Take action

Contact the company & request your remedy

Recalling firmPfizer Inc.235 E 42nd St, N/A · New York, NY 10017-5703
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Pfizer is recalling a specific clindamycin injection product due to impurities that could cause serious harm. This recall affects patients who have been prescribed this medication and requires them to check their medication details and contact Pfizer for guidance. Read more at govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm · Updated October 5, 2026 · FDA enforcement record: FDA #D-1069-2019

Cite this page

“Pfizer Cleocin Phosphate Injection Recall: Impurities Risk Serious Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm. Based on FDA recall #D-1069-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1069-2019%22&limit=1).

Why it’s dangerous

The medication contains impurities that exceed safe levels at the 24-month mark. These impurities could cause serious harm if the medication is used as intended.

Who’s affected

Patients with a prescription for this specific clindamycin injection are affected. Those who have received the medication from the recalled batch are at highest risk.

How to tell if you have this one

Check for the product name 'Cleocin Phosphate', the strength '900 mg/6 mL', and the lot number 'T78193' on the vial. The expiration date is April 2019.

  • Brand
    Pfizer
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide USA and Guam
Recall numberProduct, codes & lotsQuantityNDC
D-1067-2019Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02; Lot #: T97469, Exp. 7/2019, W28574, Exp.09/201967 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1068-2019Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-3124-01; Lot#: T78191, Exp.04/2019, T97494, Exp.07/2019820 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1069-2019Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01; Lot #: T78193, Exp.04/2019500 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1070-2019Clindamycin Injection, USP, 300 mg/ 2 mL (150 mg/mL), 2 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA.,NDC 47781-619-94; Lot: T97472 (exp 07/2019), T97473 (exp 04/2019), W28573 (exp 09/2019), W31814 (exp 10/2019)701 cartons (25 vials per carton)—
D-1071-2019Clindamycin Injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC 47781-620-94; Lot #: T97496, Exp.04/2019, T97497, Exp.07/2019, W28564(exp 09/2019), W31812, Exp. 10/2019.8,878 cartons (25 vials per carton)—
D-1072-2019Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA. NDC 47781-621-94; Lot #: T96398, Exp.07/2019, T97492, Exp.04/2019, W28567, Exp. 09/2019, W31813, Exp.10/20198,320 cartons (25 vials per carton)—
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Look for the product name 'Cleocin Phosphate', strength '900 mg/6 mL', and lot number 'T78193' on the vial.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall indicates impurities that could cause serious harm, so it is not safe to use the recalled product.

How do I know if I have the recalled product?

Check for the product name 'Cleocin Phosphate', strength '900 mg/6 mL', and lot number 'T78193' on the vial.

What should I do if I have the recalled product?

Contact Pfizer directly for guidance on what to do with the medication.

Take action

Contact Pfizer

We’ve drafted a message you can send Pfizer to request your refund or repair — edit it as you like.

Subject: Recall D-1069-2019 — Pfizer Pfizer

Hello,

I own a Pfizer that is covered by recall D-1069-2019 from Pfizer.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1069-2019 (March 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1069-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA